Tissue Engineering Solutions for Cleft Palates

Journal of Oral and Maxillofacial Surgery

Volumn 65, Issue 12, 2007, Pages 2503-2511

  Moreau, Jennifer L ^a   Caccamese, John F ^b   Coletti, Dominick P ^b   Sauk, John J ^c   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^c UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HYALURONIC ACID; HYDROXYAPATITE; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ALVEOLAR BONE; ARTICLE; BIRTH DEFECT; BONE GRAFT; CHILD; CLEFT LIP PALATE; CLEFT PALATE; CRANIOFACIAL MALFORMATION; DONOR SITE; HUMAN; MORBIDITY; NONHUMAN; PREVALENCE; RAT; TECHNOLOGY; TISSUE ENGINEERING; TREATMENT INDICATION;

ALVEOLAR PROCESS; BONE TRANSPLANTATION; CLEFT LIP; CLEFT PALATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 36148987621     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2007.06.648     Document Type: Article

References (67)

1. Fallin M.D., Hetmanski J.B., Park J., et al. Family-based analysis of MSX1 haplotypes for association with oral clefts. Genet Epidemiol 25 (2003) 168
2. Sandy J.R. Molecular, clinical and political approaches to the problem of cleft lip and palate. Surgeon 1 (2003) 9
3. Zhang Z., Song Y., Zhao X., et al. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129 (2002) 4135
4. De La Pedraja J., Erbella J., McDonald W.S., et al. Approaches to cleft lip and palate repair. J Craniofac Surg 11 (2000) 562
5. Sadove A.M., van Aalst J.A., and Culp J.A. Cleft palate repair: Art and issues. Clin Plast Surg 31 (2004) 231
6. Marazita M.L., Murray J.C., Lidral A.C., et al. Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am J Hum Genet 75 (2004) 161
7. Waite P.D., and Waite D.E. Bone grafting for the alveolar cleft defect. Semin Orthod 2 (1996) 192
8. Vig K.W. Alveolar bone grafts: The surgical/orthodontic management of the cleft maxilla. Ann Acad Med Singapore 28 (1999) 721
9. Batra P., Sharma J., Duggal R., et al. Secondary bone grafting in cleft lip and palate with eruption of tooth into the graft: A case report. J Indian Soc Pedod Prev Dent 22 (2004) 8
10. Logeart-Avramoglou D., Anagnostou F., Bizios R., et al. Engineering bone: Challenges and obstacles. J Cell Mol Med 9 (2005) 72
11. Hutmacher D.W., and Garcia A.J. Scaffold-based bone engineering by using genetically modified cells. Gene 347 (2005) 1
12. Sharma B., and Elisseeff J.H. Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng 32 (2004) 148
13. Liu X., and Ma P.X. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 32 (2004) 477
14. Solchaga L.A., Yoo J.U., Lundberg M., et al. Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res 18 (2000) 773
15. Sachlos E., Reis N., Ainsley C., et al. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials 24 (2003) 1487
16. Tsuruga E., Takita H., Itoh H., et al. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem (Tokyo) 121 (1997) 317
17. Gutowska A., Jeong B., and Jasionowski M. Injectable gels for tissue engineering. Anat Rec 263 (2001) 342
18. Salgado A.J., Coutinho O.P., and Reis R.L. Bone tissue engineering: State of the art and future trends. Macromol Biosci 4 (2004) 743
19. Elmengaard B., Bechtold J.E., and Soballe K. In vivo effects of RGD-coated titanium implants inserted in two bone-gap models. J Biomed Mater Res A 75 (2005) 249
20. Goshima J., Goldberg V.M., and Caplan A.I. Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic. Biomaterials 12 (1991) 253
21. Haynesworth S.E., Goshima J., Goldberg V.M., et al. Characterization of cells with osteogenic potential from human marrow. Bone 13 (1992) 81
22. Nacamuli R.P., Wan D.C., Lenton K.A., et al. New developments in pediatric plastic surgery research. Clin Plast Surg 32 (2005) 123
23. Scott N.M., Weinberg S.M., Neiswanger K., et al. Dermatoglyphic pattern types in subjects with nonsyndromic cleft lip with or without cleft palate (CL/P) and their unaffected relatives in the Philippines. Cleft Palate Craniofac J 42 (2005) 362
24. van den Boogaard M.J., Dorland M., Beemer F.A., et al. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 24 (2000) 342
25. Alappat S., Zhang Z.Y., and Chen Y.P. Msx homeobox gene family and craniofacial development. Cell Res 13 (2003) 429
26. Ito Y., Yeo J.Y., Chytil A., et al. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130 (2003) 5269
27. Sun D., Vanderburg C.R., Odierna G.S., et al. TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development 125 (1998) 95
28. Wong F.K., and Hagg U. An update on the aetiology of orofacial clefts. Hong Kong Med J 10 (2004) 331
29. Marçano A.C., Doudney K., Braybrook C., et al. TBX22 mutations are a frequent cause of cleft palate. J Med Genet 41 (2004) 68
30. Turhani D., Item C.B., Watzinger E., et al. Mutation analysis of CLPTM 1 and PVRL 1 genes in patients with non-syndromic clefts of lip, alveolus and palate. J Craniomaxillofac Surg 33 (2005) 301
31. Cobourne M.T. The complex genetics of cleft lip and palate. Eur J Orthod 26 (2004) 7
32. Kondo S., Schutte B.C., Richardson R.J., et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32 (2002) 285
33. Hollinger J.O., and Winn S.R. Tissue engineering of bone in the craniofacial complex. Ann NY Acad Sci 875 (1999) 379
34. Jadlowiec J.A., Celil A.B., and Hollinger J.O. Bone tissue engineering: Recent advances and promising therapeutic agents. Expert Opin Biol Ther 3 (2003) 409
35. Furumatsu T., Shen Z.N., Kawai A., et al. Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem (Tokyo) 133 (2003) 633
36. Shimakura Y., Yamzaki Y., and Uchinuma E. Experimental study on bone formation potential of cryopreserved human bone marrow mesenchymal cell/hydroxyapatite complex in the presence of recombinant human bone morphogenetic protein-2. J Craniofac Surg 14 (2003) 108
37. Xiao Y., Qian H., Young W.G., et al. Tissue engineering for bone regeneration using differentiated alveolar bone cells in collagen scaffolds. Tissue Eng 9 (2003) 1167
38. Paganelli C., Fontana P., Porta F., et al. Indications on suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate. J Oral Rehabil 33 (2006) 625
39. Letic-Gavrilovic A., Piattelli A., and Abe K. Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth. J Mater Sci Mater Med 14 (2003) 95
40. Marei M.K., Nouh S.R., Fata M.M., et al. Fabrication of polymer root form scaffolds to be utilized for alveolar bone regeneration. Tissue Eng 9 (2003) 713
41. Marei M.K., Nouh S.R., Saad M.M., et al. Preservation and regeneration of alveolar bone by tissue-engineered implants. Tissue Eng 11 (2005) 751
42. Suganuma J., and Alexander H. Biological response of intramedullary bone to poly-L-lactic acid. J Appl Biomater 4 (1993) 13
43. van Sliedregt A., van Loon J.A., van der Brink J., et al. Evaluation of polylactide monomers in an in vitro biocompatibility assay. Biomaterials 15 (1994) 251
44. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: Molecular clones and activities. Science 242 (1988) 1528
45. Carstens M.H., Chin M., Ng T., et al. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): Role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg 16 (2005) 1023
46. Chin M., Ng T., Tom W.K., et al. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg 16 (2005) 778
47. Mayer M., Hollinger J., Ron E., et al. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast Reconstr Surg 98 (1996) 247
48. Boyne P.J., Nath R., and Nakamura A. Human recombinant BMP-2 in osseous reconstruction of simulated cleft palate defects. Br J Oral Maxillofac Surg 36 (1998) 84
49. Ouyang X.Y., and Qiao J. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans. Chin Med J 119 (2006) 1511
50. Hibi H., Yamada Y., Ueda M., et al. Alveolar cleft osteoplasty using tissue engineered osteogenic material. Int J Oral Maxillofac Surg 35 (2006) 551
51. Zadeh H.H. Implant site development: Clinical realities of today and the prospects of tissue engineering. J Calif Dent Assoc 32 (2004) 1011
52. Feinberg S.E., Aghaloo T.L., and Cunningham Jr. L.L. Role of tissue engineering in oral and maxillofacial reconstruction: Findings of the 2005 AAOMS Research Summit. J Oral Maxillofac Surg 63 (2005) 1418
53. Ophof R., van Rheden R.E., Von den H.J., et al. Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue. Biomaterials 23 (2002) 3741
54. Izumi K., Feinberg S.E., Iida A., et al. Intraoral grafting of an ex vivo produced oral mucosa equivalent: A preliminary report. Int J Oral Maxillofac Surg 32 (2003) 188
55. Izumi K., Terashi H., Marcelo C.L., et al. Development and characterization of a tissue-engineered human oral mucosa equivalent produced in a serum-free culture system. J Dent Res 79 (2000) 798
56. Aalami O.O., Nacamuli R.P., Lenton K.A., et al. Applications of a mouse model of calvarial healing: Differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg 114 (2004) 713
57. Aalami O.O., Nacamuli R.P., Salim A., et al. Differential transcriptional expression profiles of juvenile and adult calvarial bone. Plast Reconstr Surg 115 (2005) 1986
58. Cowan C.M., Quarto N., Warren S.M., et al. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 278 (2003) 32005
59. Caplan A.I., Reuben D., and Haynesworth S.E. Cell-based tissue engineering therapies: The influence of whole body physiology. Adv Drug Deliv Rev 33 (1998) 3
60. Service R.F. Tissue engineers build new bone. Science 289 (2000) 1498
61. Stenderup K., Justesen J., Clausen C., et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33 (2003) 919
62. Bierman E.L. The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells. In Vitro 14 (1978) 951
63. Schneider E., and Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA 73 (1976) 3584
64. Mulliken J.B. The changing faces of children with cleft lip and palate. N Engl J Med 351 (2004) 745
65. Farkas L.G., Posnick J.C., Hreczko T.M., et al. Growth patterns of the nasolabial region: A morphometric study. Cleft Palate Craniofac J 29 (1992) 318
66. Shin'oka T., Matsumura G., Hibino N., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330
67. Isomatsu Y., Shin'oka T., Matsumura G., et al. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 126 (2003) 1958